5 Best One Dollar Stocks to Buy Now

2. AzurRx BioPharma, Inc. (NASDAQ: AZRX)

Stock Price as of July 16: $0.68
Number of Hedge Fund Holders: 2

AzurRx BioPharma, Inc. (NASDAQ: AZRX) ranks 2nd on the list of 10 best one dollar stocks to buy now. The Florida-based clinical-stage biopharmaceutical company develops non-systemic therapies for gastrointestinal diseases. The first patient in Phase 2 clinical trial of oral niclosamide to treat COVID-19 gastrointestinal infections was dosed in June by AzurRx BioPharma, Inc. (NASDAQ: AZRX). The trial’s topline results are expected in the first quarter of 2022.

In April, H.C. Wainwright analyst Yi Chen maintained a Buy rating on AzurRx BioPharma, Inc. (NASDAQ: AZRX) and reduced the price target to $2.50 from $3.50. The analyst forecasted a moderately lower probability of endorsement for AzurRx BioPharma, Inc.’s exocrine pancreatic insufficiency treatment, MS1819, down to 60% from 65%, and pushed back potential market entry to 2024 from 2023.

The company has a market cap of $53.4 million. In the first quarter of 2021, AzurRx BioPharma, Inc. (NASDAQ: AZRX) had an EPS of -$0.14, up 30% year over year, but missing estimates by $0.07. The company had roughly $6.1 million in cash and cash equivalents as of December 31, 2020. 

At the end of the first quarter of 2021, 2 hedge funds in the database of Insider Monkey held stakes worth $143,000 in AzurRx BioPharma, Inc. (NASDAQ: AZRX), up from 1 in the previous quarter worth $181,000.